Daily non-political popular news in brief.

New breakthrough treatment for spinal cancer patients at Mount Sinai

The Mount Sinai Medical Center is the only hospital in New York City using the Novalis Shaped Beam Surgery System on spinal cancer. Novalis is the most advanced Stereotactic Radiosurgery technology available to treat cancer tumors in the spine. Doctors at Mount Sinai are at the forefront of this medical breakthrough in neurosurgery and radiation oncology, using this technology to control deadly and complicated tumors from the spine for the first time ever.

Read more »

Keywords: breakthrough, treatment, spinal, cancer, patients, mount, sinai, patient

« Previous | Next »

Similar news on "New breakthrough treatment for spinal cancer patients at Mount Sinai":

1. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
   01-31-2008 · EurekAlert!
   Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
   Similar news · Read more »
   
2. Further breakthroughs for breast cancer patients
   01-18-2008 · EurekAlert!
   Researchers at the Tenovus Centre for Cancer Research at Cardiff University have made a breakthrough in breast cancer treatment that could help save the lives of women who become resistant to breast cancer drugs such as tamoxifen.
   Similar news · Read more »
   
3. MRI detects cancers missed by mammography in breast cancer patients
   06-02-2007 · EurekAlert!
   A unique examination of one treatment center's use of magnetic resonance imaging (MRI) in new breast cancer patients has found MRI to be superior to mammography in finding additional tumors in a breast in which cancer has already been diagnosed, and in detecting new tumors in a patient’s supposedly healthy breast.
   Similar news · Read more »
   
4. From clinical cancer research: rethinking therapeutic cancer vaccine trials
   07-03-2007 · EurekAlert!
   Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, a team of National Cancer Institute researchers asks a fundamental question: are we looking at cancer vaccine trials the wrong way?
   Similar news · Read more »
   
5. New hope for Huntington's sufferers
   08-22-2007 · EurekAlert!
   A major breakthrough in the understanding and potential treatment of Huntington's disease has been made by scientists at the University of Leeds. Researchers in the university's Faculty of Biological Sciences have discovered that one of the body's naturally occurring proteins is preventing 57 genes from operating normally in the brains of Huntington's sufferers. In addition, the destructive nature of this protein could potentially be halted using drugs that are already being used to help cancer patients.
   Similar news · Read more »
   
6. Patient navigators help minority, low-income cancer patients get life-saving treatments
   10-28-2007 · EurekAlert!
   Volunteers who guide low-income and minority cancer patients through cancer treatment, called lay patient navigators, help them to overcome major obstacles that prevent them from receiving quality care and achieving better outcomes, according to a study presented Oct. 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
   Similar news · Read more »
   
7. Mayo Clinic Cancer Center -- individualizing treatment for multiple myeloma patients
   12-10-2006 · EurekAlert!
   Researchers at Mayo Clinic Cancer Center, in cooperation with industry partners, have, for the first time, identified tumor specific alterations in the cellular pathway by which the multiple myeloma drug bortezomib (Velcade) works, and they have identified nine new genetic mutations in cancer cells that should increase a patient's chance of responding to the agent.
   Similar news · Read more »
   
8. Cancer care providers need to proactively address patients' psychological and social needs
   10-23-2007 · EurekAlert!
   Cancer care that focuses solely on eradicating tumors without addressing the patient's general well-being can increase patients' suffering, may compromise their ability to follow through on treatment, and falls short of achieving quality care, says a new report from the Institute of Medicine.
   Similar news · Read more »
   
9. Second SPORT Study Shows Surgery Advantage for Spinal Stenosis and Slipped Vertebra
   05-30-2007 · EurekAlert!
   In one of the three most common back conditions for which patients seek treatment, surgery proved to have substantially better results than non-surgical remedies, according to Dartmouth-led research published in the May 31 New England Journal of Medicine. The paper is the second in a series detailing the findings of the Spine Patient Outcomes Research Trial (SPORT), a seven-year, $21 million national study funded by the National Institutes of Health.
   Similar news · Read more »
   
10. Quantitative PET imaging finds early determination of effectiveness of cancer treatment
    10-23-2007 · EurekAlert!
    With positron emission tomography imaging, seeing is believing: evaluating a patient's response to chemotherapy for non-Hodgkin lymphoma typically involves visual interpretation of scans of cancer tumors. Researchers have found that measuring a quantitative index -- one that reflects the reduction of metabolic activity after chemotherapy first begins -- adds accurate information about patients' responses to first-line chemotherapy, according to a study in the October issue of the Journal of Nuclear Medicine.
    Similar news · Read more »